-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Interface of Complement and Coagulation

PhD Trainee
Program: Scientific Symposia
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Hemoglobinopathies, Diseases, Biological Processes, Maternal Health
Saturday, December 7, 2024: 4:00 PM-5:15 PM
Room 33 (San Diego Convention Center)
Chair:
David Kavanagh, New Castle University
Disclosures:
Kavanagh: Gyroscope Therapeutics: Ended employment in the past 24 months, Honoraria, Patents & Royalties, Research Funding; Novartis: Honoraria; Alexion: Honoraria, Research Funding; Sarepta: Honoraria; Silence Therapeutics: Honoraria; Samsung: Honoraria; Amgen: Honoraria; Chemocentryx: Honoraria; Apellis: Honoraria.

The complement system and coagulation pathways are the main pillars of immunity and hemostasis respectively that undergo significant activation with injury. While appearing distinct, it is recognized that significant crosstalk exists between the two systems and recently established molecular mechanisms provide insights into a wide variety of disorders. This session will focus on new molecular links identified in complement activation in specific and highly relevant clinical disorders.

David Kavanagh

New Castle University, Newcastle Upon Tyne, United Kingdom

Efthymia Vlachaki, Consultant Hematologist

Adults Thalassemia Unit, Hippokrateon Hospital, Thessaloniki, Greece

Lubka T Roumenina, PhD

INSERM UMRS1138 Cordeliers Research Center, Paris, France

See more of: Scientific Symposia